Login
← Go Back
Astrazeneca Pharma India
ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in
Stock Price vs Company Growth
1d
2.9%
1w
5.0%
1m
10.9%
3m
22.6%
6m
18.1%
1y
27.9%
5y
15.6%
10y
21.0%
all
13.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 6,330 2.9%
6,267
8,498
Company Overview
Sales
2,432 Cr
Growth: 25.7%
Profit after Tax
168 Cr
Growth: -9.6%
Mid Cap
15,825 Cr
P/E: 92.7x
Industry P/E: 35.1x
Fundamentals
Sales (Cr) ₹ 2,432
Growth 25.7%
EBITDA 9.5%
P/S 6.5x
Dividend 0.3%
P/E 92.7x
Book Value ₹ 364
PEG Ratio 3.7x
ROE 18.8%
P/B 17.9x
Shareholding Pattern
Institutions
Promoters
Astrazeneca Pharmaceuticals Ab
75.0 %
Others
Tejas Bhalchandra Trivedi
2.67 %
Shivani T. Trivedi
1.98 %
Minaxi Bhalchandra Trivedi
1.84 %
Iepf
0.46 %
Increase    Decrease    No change
Company Profile Detailed
AstraZeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. The company engages in execution of clinical studies to generate high quality data eligible for submissions to regulatory agencies across the world aimed at developing life altering medical products.
Belongs to (15 Indices) view more
Investors (43)
shivani....
astra.ph...
all.body...
Followers (3)
nitin2
keerthi
deepak